PROSTATE CANCER METASTATIC
Clinical trials for PROSTATE CANCER METASTATIC explained in plain language.
Never miss a new study
Get alerted when new PROSTATE CANCER METASTATIC trials appear
Sign up with your email to follow new studies for PROSTATE CANCER METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can less be more? prostate cancer drug dose study aims to cut side effects
Disease control TerminatedThis study looked at whether a lower dose of the prostate cancer drug abiraterone can still control the disease. About 50 men with prostate cancer who were starting abiraterone for the first time took part. The goal was to find the smallest effective dose by measuring hormone lev…
Matched conditions: PROSTATE CANCER METASTATIC
Phase: PHASE1 • Sponsor: University of Chicago • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
Experimental prostate cancer drug trial halted early
Disease control TerminatedThis study tested a new drug called LAE001 in 33 men with metastatic prostate cancer that had stopped responding to hormone therapy. The goal was to check safety and find the right dose, and later see if it could lower PSA levels. The trial was terminated early, so results are li…
Matched conditions: PROSTATE CANCER METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: Laekna Limited • Aim: Disease control
Last updated May 18, 2026 12:09 UTC